Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

MLTXMLTX
Showing 7 of 11 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in MOONLAKE IMMUNOTHERAPEUTICS

Point72 Asset Management, L.P. holds 1.2M shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), worth $22.6M as of 2026-Q2. The position was decreased (-15.3% shares). MLTX represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$22.6M

Current Shares

1.2M

Total Value Change

+$17.2M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-15.3%
$22.6M0.0%$19.47
0
2026-Q1
Increased
1.4M
+77.2%
$25.5M0.0%$17.69
43
2025-Q4
Increased
772,500
+7782.6%
$10.2M0.0%$13.21
45
2025-Q3
Decreased
9,800
-94.8%
$70,2660.0%$6.24
0
2025-Q2
New
186,568
-
$8.8M0.0%$47.52
38
2025-Q1
Exited
0
-100.0%
$00.0%$39.86
0
2024-Q4
New
98,719
-
$5.3M0.0%$53.02
37

Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used